- Report
- August 2024
- 100 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- May 2024
- 137 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- February 2025
- 184 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- November 2023
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- March 2022
- 300 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- August 2022
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- December 2023
- 300 Pages
Global
From €2397EUR$2,500USD£2,003GBP
- Report
- June 2023
- 22 Pages
Global
€11744EUR$12,250USD£9,812GBP
- Report
- September 2022
- 39 Pages
Global
From €1917EUR$2,000USD£1,602GBP
The Thyroid Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat thyroid disorders, such as hypothyroidism, hyperthyroidism, and thyroid cancer. These drugs are used to regulate the production of hormones in the body, and to reduce the symptoms of thyroid disorders. Commonly prescribed drugs include levothyroxine, liothyronine, and calcitonin.
Thyroid drugs are available in both prescription and over-the-counter forms. They are typically taken orally, although some may be administered intravenously. The market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Merck, Pfizer, Sanofi, and Novartis. Show Less Read more